Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
729 days ago
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
995 days ago
FTSE 100 Modestly Higher
The UK stock market is modestly higher a little past noon on Tuesday amid expectations of a Ukraine peace deal. Investors are also looking ahead to the Federal Reserve's economic symposium at Jackson Hole, Wyoming, that gets underway on Thursday.
RTTNews
|
5 minutes ago
Swiss Franc Rises Against Majors
The Swiss franc strengthened against other major currencies in the European session on Tuesday.
RTTNews
|
24 minutes ago
CAC 40 Rises 0.8% As Ukraine Peace Deal Hopes Lift Sentiment
The French market is notably higher on Tuesday as investors pick up stocks amid hopes of a Russia - Ukraine peace deal after U.S. President Donald Trump described his meeting with Ukrainian President Volodymyr Zelenskyy and several other European leaders as "very good".
RTTNews
|
50 minutes ago
Home Depot Q2 Profit Down, Misses Street, But Comps Rise; Backs FY25 Outlook
Home Depot Inc. reported Tuesday slightly lower profit in its second quarter, despite higher sales and comparable sales. Meanwhile, Adjusted earnings per share and top line missed market estimates. Further, the company maintained its outlook for fiscal 2025 earnings and sales growth.
RTTNews
|
57 minutes ago
Sensex, Nifty Extend Gains On Economic Optimism
Indian shares rose modestly on Tuesday, extending gains from the previous session amid hopes that Prime Minister Modi's recent GST reforms will potentially ease inflation and pave the way for further rate cuts by the Reserve Bank of India (RBI).
RTTNews
|
1h 9min ago
DAX Up 0.3% On Ukraine Peace Deal Hopes
German stocks are gaining some ground in positive territory on Tuesday amid hopes of a peace deal between Russia and Ukraine, after U.S. President Donald Trump said his recent meeting with Ukrainian President Volodymyr Zelenskyy and other European leaders progressed well.
RTTNews
|
1h 21min ago
